Elevated circulating levels of macrophage migration inhibitory factor in polycystic ovary syndrome
Authors:
- 1 September 2010
- Vol. 51 (3) , 240-244
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteriaHuman Reproduction, 2009
- Plasma monocyte chemoattractant protein‐1 (MCP‐1) and macrophage inflammatory protein‐1α are increased in patients with polycystic ovary syndrome (PCOS) and associated with adiposity, but unaffected by pioglitazone treatmentClinical Endocrinology, 2009
- Macrophage Migration Inhibitory Factor in Cardiovascular DiseaseCirculation, 2008
- Obese Reproductive‐Age Women Exhibit a Proatherogenic Inflammatory Response During HyperglycemiaObesity, 2007
- Macrophage Migration Inhibitory Factor: Gene Polymorphisms and Susceptibility to Inflammatory DiseasesClinical Infectious Diseases, 2005
- ChemokinesArteriosclerosis, Thrombosis, and Vascular Biology, 2004
- Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndromeFertility and Sterility, 2004
- Relation of intra-abdominal fat distribution to metabolic disorders in nonobese patients with polycystic ovary syndromeFertility and Sterility, 2003
- ENHANCEMENT OF OXIDISED LOW-DENSITY LIPOPROTEIN UPTAKE BY MACROPHAGES IN RESPONSE TO MACROPHAGE MIGRATION INHIBITORY FACTORCytokine, 2000
- Effects of Androgens on Coronary Artery Atherosclerosis and Atherosclerosis-Related Impairment of Vascular ResponsivenessArteriosclerosis, Thrombosis, and Vascular Biology, 1995